AAAAAA
Results:
1-7
|
Results: 7
Authors:
Heinig, R
Zimmer, D
Yeh, S
Krol, GJ
Citation: R. Heinig et al., Development, validation and application of assays to quantify metrifonate and 2,2-dichlorovinyl dimethylphosphate in human body fluids, J CHROMAT B, 741(2), 2000, pp. 257-269
Authors:
Heinig, R
Kitchin, N
Rolan, P
Citation: R. Heinig et al., Disposition of a single dose of warfarin in healthy individuals after pretreatment with metrifonate, CLIN DRUG I, 18(2), 1999, pp. 151-159
Authors:
Heinig, R
Dietrich, H
Halabi, A
Citation: R. Heinig et al., Pharmacokinetics of metrifonate and its metabolite dichlorvos in healthy volunteers and in patients with renal impairment, CLIN DRUG I, 18(1), 1999, pp. 35-46
Authors:
Heinig, R
Boettcher, M
Herman-Gnjidic, Z
Pierce, CH
Citation: R. Heinig et al., Effects of a magnesium aluminium hydroxide containing antacid, cimetidine or ranitidine on the pharmacokinetics of metrifonate and its metabolite DDVP, CLIN DRUG I, 17(1), 1999, pp. 67-77
Authors:
Heinig, R
Sachse, R
Citation: R. Heinig et R. Sachse, The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate, INT J CL PH, 37(9), 1999, pp. 456-464
Authors:
Dingemanse, J
Halabi, A
Kleinbloesem, CH
Heinig, R
Blume, H
Citation: J. Dingemanse et al., Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment, THER DRUG M, 21(3), 1999, pp. 310-316
Authors:
Heinig, R
Adelmann, HG
Ahr, G
Citation: R. Heinig et al., The effect of ketoconazole on the pharmacokinetics, pharmacodynamics and safety of nisoldipine, EUR J CL PH, 55(1), 1999, pp. 57-60
Risultati:
1-7
|